Search filters

List of works by Craig C Hofmeister

Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia

scientific article published on 01 September 2021

Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantation

scientific article

Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin lymphomas

scientific article

Autologous hematopoietic stem cell transplant induces the molecular aging of T-cells in multiple myeloma

scientific article

BEAM versus BUCYVP16 Conditioning before Autologous Hematopoietic Stem Cell Transplant in Patients with Hodgkin Lymphoma

scientific article published on 01 February 2019

Central nervous system post-transplant lymphoproliferative disorder despite negative serum and spinal fluid Epstein-Barr virus DNA PCR.

scientific article published in February 2007

Characterization of multiple myeloma vesicles by label-free relative quantitation.

scientific article published on October 2013

Chemotherapeutic agents increase the risk for pulmonary function test abnormalities in patients with multiple myeloma

scientific article

Chromatin Accessibility Identifies Regulatory Elements Predictive of Gene Expression and Disease Outcome in Multiple Myeloma

scientific article published on 17 March 2021

Conflicts of interest, authorship, and disclosures in industry-related scientific publications

scientific article

Correction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation

scientific article

Daratumumab induces CD38 internalization and impairs myeloma cell adhesion

scientific article published on 23 July 2018

Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS)

scientific article published on 05 February 2020

Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma

scientific article published in 2022

Development and validation of a highly sensitive liquid chromatography/mass spectrometry method for simultaneous quantification of lenalidomide and flavopiridol in human plasma

scientific article

Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myeloma

scientific article published on 31 December 2012

Effects of induction with novel agents versus conventional chemotherapy on mobilization and autologous stem cell transplant outcomes in multiple myeloma

scientific article published on February 2010

Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC.

scientific article published on 26 October 2013

FLT3L and plerixafor combination increases hematopoietic stem cell mobilization and leads to improved transplantation outcome.

scientific article published on 21 December 2013

Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone

scientific article published on 25 November 2019

Graft-versus-host disease of the skin: life and death on the epidermal edge.

scientific article published on June 2004

Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning

scientific article published on 28 February 2011

IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect

scientific article

Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies

scientific article published on September 2009

In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation

scientific article published on 22 April 2013

Initial genome sequencing and analysis of multiple myeloma

scientific article

Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials

scientific article published on 24 February 2020

Ixazomib maintenance therapy in newly diagnosed multiple myeloma: An integrated analysis of four phase I/II studies

scientific article published on 08 May 2019

Lenalidomide after stem-cell transplantation for multiple myeloma

scientific article

Lenalidomide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed multiple myeloma: a phase 1/2 Multiple Myeloma Research Consortium trial

scientific article

Long-Term Therapy with Lenalidomide in a Patient with POEMS Syndrome

scientific article

MicroRNAs activate natural killer cells through Toll-like receptor signaling ⬇️

scientific article published on April 11, 2013

Multiple myeloma immunoglobulin lambda translocations portend poor prognosis

scientific article published on 23 April 2019

Phase 1 study of marizomib in relapsed or relapsed and refractory multiple myeloma: NPI-0052-101 Part 1

scientific article

Phase II clinical trial of arsenic trioxide with liposomal doxorubicin, vincristine, and dexamethasone in newly diagnosed multiple myeloma

scientific article published on 21 December 2007

Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study

scientific article published on 13 January 2014

Population pharmacokinetics of lenalidomide in patients with B-cell malignancies

scientific article published on 27 February 2019

Psychosocial risk predicts high readmission rates for hematopoietic cell transplant recipients.

scientific article published on 14 February 2018

Retrospective utility of bronchoscopy after hematopoietic stem cell transplant

scientific article published on 18 September 2006

Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom's macroglobulinemia

scientific article published on 4 December 2017

Sensitive liquid chromatography/mass spectrometry methods for quantification of pomalidomide in mouse plasma and brain tissue

scientific article

Serum free light chains in myeloma patients with an intact M protein by immunofixation: potential roles for response assessment and prognosis during induction therapy with novel agents

scientific article published on 26 October 2011

TTP disease course is independent of myeloma treatment and response

scientific article

The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody

scientific article

The novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-cell malignancies in vitro and in vivo

scientific article (publication date: 3 June 2010)

The potential of miRNAs as biomarkers for multiple myeloma

scientific article published on 07 August 2014

Unique Pattern of Renal κ Light Chain Amyloid Deposition With Histiocytic Transdifferentiation of Tubular Epithelial Cells

scientific article published on 01 August 2012

Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial

scientific article

Use of a comprehensive frailty assessment to predict morbidity in patients with multiple myeloma undergoing transplant

scientific article published on 6 July 2018

Venetoclax ex vivo functional profiling predicts improved progression-free survival

scientific article published in 2022

Paulina is supported by:

About Paulina

Help